Walt Disney Co vs Roivant Sciences Ltd. Common Shares — how do they compare? Walt Disney Co trades at $107.01 (market cap $180.87B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Walt Disney Co is far larger — about 7.2× Roivant Sciences Ltd. Common Shares's market cap, and Walt Disney Co pays a 1.43% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Walt Disney Co for 199 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| DIS | ROIV | |
|---|---|---|
Market Cap | $180.87B | $25.09B |
Volume | 7,385,182 | 5,738,571 |
Sector | Media | Health |
52-Week High | $116.65 | $41.81 |
52-Week Low | $92.40 | $16.04 |
Typical Hold Time | 199 Days | 0 Days |
Enterprise Value | $221.73B | $21.36B |
Dividend Yield | 1.43% | — |
Signals from Pluang's Aura AI — not financial advice
Disney (DIS) trades at $107.08, up 2.93% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with revenue growth from $91.4B to $94.4B in 2025 and net income surging to $12.4B. Recent earnings beats and a $60B parks investment highlight strategic expansion. Analyst consensus remains strongly positive with a $125.67 price target, representing 17% upside potential from current levels.
Disney presents a compelling investment opportunity with accelerating profitability and strategic investments in experiences and streaming. Key risks include free cash flow pressure from elevated capital expenditures and competitive streaming landscape challenges. The stock's current valuation at 21.6x P/E appears reasonable given growth trajectory, though execution on content investments and margin expansion will be critical for sustained outperformance.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The Walt Disney Company is an entertainment company with operations in media networks, park experiences & consumer products, studio entertainment and Direct-to-Consumer networks and channels. The Company serves customers worldwide.
Read more on DIS →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →